Latest Articles
- Shark cartilage: the Laetrile of the 1990s
Shark cartilage, like Laetrile, high-dose vitamin C, and coffee enemas, provides patients with emotional support, but does nothing to the cancer.
- Commentary on the new Quide to Clinical Preventive Services
The long-awaited recommendations from the US Preventive Services Task Force are useful, but too narrow. Some suggested modifications.
- The clinical role of platelet glycoprotein Ilb/IIIa receptor inhibitors in ischemic heart disease
These new drugs show great promise in reducing the complications of angioplasty and acute coronary syndromes.
- The injured worker: assessing “return-to-work” status
Psychological, economic, social, and legal factors are often as important as physical findings in a return-to-work assessment.
- Cardiovascular disease in renal failure: risk assessment, screening, treatment
Half of ESRD deaths are due to cardiovascular disease. Some strategies for identifying and treating high-risk patients.
- Cardiac rehabilitation: not just exercise anymore
The treatment of sicker patients and shorter hospital stays are forcing a rethinking of approaches to cardiac rehabilitation.
- Fibromyalgia: more than a label
Fibromyalgia is a useful diagnosis that can reduce wasteful testing and treatment.
- Managing lupus nephritis: algorithms for conservative use of renal biopsy
Despite the widespread use of renal biopsy, lupus nephritis can usually be managed on the basis of clinical presentation alone.
- Cholesterol lowering: perspectives on the 4S and West of Scotland studies
Recent studies have resolved lingering doubts about cholesterol-lowering therapy, but questions on lipid management remain.